{"name":"Uptown Eye Specialists","slug":"uptown-eye-specialists","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Brimonidine Tartrate 0.15% Oph Soln","genericName":"Brimonidine Tartrate 0.15% Oph Soln","slug":"brimonidine-tartrate-0-15-oph-soln","indication":"Other","status":"phase_1"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Zocular Eyelid System Treatment","genericName":"Zocular Eyelid System Treatment","slug":"zocular-eyelid-system-treatment","indication":"Meibomian gland dysfunction","status":"marketed"}]}],"pipeline":[{"name":"Brimonidine Tartrate 0.15% Oph Soln","genericName":"Brimonidine Tartrate 0.15% Oph Soln","slug":"brimonidine-tartrate-0-15-oph-soln","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Zocular Eyelid System Treatment","genericName":"Zocular Eyelid System Treatment","slug":"zocular-eyelid-system-treatment","phase":"marketed","mechanism":"The Zocular Eyelid System Treatment is a thermal pulsation device that applies controlled heat and pressure to the eyelids to liquefy and express meibum from blocked meibomian glands.","indications":["Meibomian gland dysfunction","Evaporative dry eye disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}